Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.04M | -23.46M | -28.44M | -28.37M | -22.81M |
| Total Depreciation and Amortization | 580.00K | 599.00K | 609.00K | 651.00K | 646.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.39M | 6.06M | 9.11M | 9.45M | 7.38M |
| Change in Net Operating Assets | 1.66M | -1.25M | 1.40M | 9.09M | 5.07M |
| Cash from Operations | -12.41M | -18.05M | -17.32M | -9.19M | -9.71M |
| Capital Expenditure | -742.00K | -722.00K | -570.00K | -591.00K | -458.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 7.27M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -742.00K | -722.00K | -570.00K | -591.00K | 6.81M |
| Total Debt Issued | -- | -- | 34.19M | 34.19M | 34.19M |
| Total Debt Repaid | -20.00K | -20.00K | -11.05M | -11.06M | -11.06M |
| Issuance of Common Stock | 7.00M | 7.00M | 0.00 | 30.00K | 86.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -205.00K | -235.00K | 694.00K | 841.00K | 841.00K |
| Cash from Financing | 6.78M | 6.75M | 23.83M | 24.00M | 24.05M |
| Foreign Exchange rate Adjustments | 104.00K | 113.00K | -58.00K | -22.00K | -122.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.27M | -11.91M | 5.88M | 14.20M | 21.03M |